1,620 product recalls found in this category. Browse through all safety alerts and stay informed.
High Activity Category
This category has a significant number of recalls. Please check regularly for updates.
Merck Sharp & Dohme LLC recalled 51,320 cartons of Belsomra (suvorexant) tablets on July 21, 2025. The recall stems from a failure in dissolution specifications that could delay drug release. Consumers should stop using the product immediately and consult healthcare providers for guidance.
AUM Pharmaceuticals recalled 50,000 cartons of Quick Touch Alcohol Prep Pads on July 21, 2025, due to cGMP deviations. The recall affects sterile pads containing 70% isopropyl alcohol. Consumers should stop using the product immediately and contact the manufacturer.
DJO Surgical recalled 907 units of the Altivate Reverse Wedge Glenoid Reamer on July 18, 2025, due to a kickback risk during use. The recall affects healthcare providers and patients nationwide across 25 states. This Class II recall warns of potential binding issues that could lead to serious injury.
DJO Surgical recalled 447 units of the Altivate Reverse Wedge Glenoid Reamer Sleeve on July 18, 2025. The recall follows reports that the device may kick or bind during use, presenting a serious hazard to patients. Healthcare providers and patients should discontinue use immediately and follow the manufacturer's instructions.
DJO Surgical recalled 439 AltiVate Reverse Glenoid Trays on July 18, 2025, due to potential reamer malfunction. The reamer may kick or bind during use, posing a serious risk to patients. Healthcare providers should stop using the device immediately and follow the recall instructions.
DJO Surgical recalled 927 units of the Altivate Reverse Wedge Glenoid Reamer Head on July 18, 2025. The recall follows reports that the device may kick or bind up during use. Healthcare providers and patients must stop using the product immediately.
C.R. Bard Inc issued a recall for 4,300 Foley catheter trays on July 17, 2025. Incorrect inserts lead to potential allergic reactions and infection risk. Healthcare providers and patients must stop using the device immediately.
C.R. Bard recalled 4,300 Foley catheter trays on July 17, 2025. Incorrect inserts may lead users to misidentify materials, increasing infection and allergic reaction risks. Patients and healthcare providers must stop using the trays immediately and follow recall instructions.
DermaRite Industries LLC recalled 249 bottles of DermaSarra External Analgesic on July 17, 2025. The product contains camphor and is contaminated with Burkholderia cepacia. This recall is classified as Class I due to the potential health risks.
DermaRite Industries recalled 5,703 bottles of PeriGiene antiseptic on July 17, 2025. The product contains Burkholderia cepacia, posing health risks. Consumers must stop using the product immediately.
Quest International recalled 376 Measles IgM Test Kits on July 17, 2025. The kits lack premarket approval or clearance from the FDA. Healthcare providers and patients must stop using these kits immediately.
DermaRite Industries LLC recalled 11,321 bags of DermaKleen antiseptic lotion soap on July 17, 2025. The product, contaminated with Burkholderia cepacia, poses a serious health risk. Consumers should stop using the product immediately and contact health providers for guidance.
DermaRite Industries recalled 6,973 cartridges of KleenFoam Antimicrobial Foam Soap on July 17, 2025. The product contains a harmful bacterial contamination, Burkholderia cepacia. Consumers should stop using the soap immediately and seek guidance from healthcare providers.
C.R. Bard recalled 3,670 Foley catheter trays on July 17, 2025, due to incorrect inserts. Users may confuse materials, leading to allergies or infections. Healthcare providers and patients must stop using these trays immediately.
Stryker Communications recalled 40 surgical light systems on July 15, 2025, due to potential powder coating chipping. This defect increases risks for healthcare providers and patients. Affected products were distributed nationwide, including Texas, Illinois, and New York.
Biofire Defense recalled 130 kits of the FilmArray NGDS Warrior Panel on July 10, 2025. The recall is due to an increased risk of internal control failures when testing positive blood cultures. These failures could delay results and require additional diagnostic workups.
Boothwyn Pharmacy recalled 648 vials of Semaglutide injection on July 9, 2025. The product is subpotent and poses a high hazard risk. Consumers should stop using the product immediately and contact their healthcare provider.
Boothwyn Pharmacy recalled 8 vials of Fluorescein 2% Ophthalmic Solution on July 9, 2025. The recall occurred due to the drug being subpotent, posing potential health risks. Consumers should stop using the product immediately and seek guidance from their healthcare provider.
Boothwyn Pharmacy recalled 186 vials of Semaglutide, 2.5 mg/mL injection on July 9, 2025. The product is subpotent and poses a risk to consumers. Healthcare providers and consumers should stop using this product immediately.
Boothwyn Pharmacy recalled 642 vials of Semaglutide injection on July 9, 2025. The recall follows the discovery that the drug is subpotent. Consumers should stop using the product immediately and seek guidance from healthcare providers.